The mechanism of CAP activity covers both receptor-dependent and non-receptor-dependent pathways, but its protective effect against neurodegeneration is mainly through transient receptor potential vanilloid 1 (TRPV1)
They should respond to technical questions about reconstitution, storage, and handling procedures
In this context, besides their well described effect on solid tumors, reprogramming tumor resident macrophages using GPX4 inhibitors could be of potential interest in solid cancer and hematopoietic malignancies including AML
is a consultant for AbbVie, Allergan, Astellas Pharma, Bayer Health Care, Gynesonics and Viteava and has received royalties from UpToDate and the Massachusetts Medical Society
Take our [free assessment quiz]( today to learn more about how a personalized plan can work for you